The American Association of Clinical Endocrinologists and the American Thyroid Association have collaborated to release new guidelines outlining the appropriate management of patients with hyperthyroidism and other causes of thyrotoxicosis.

http://www.endocrinetoday.com/view.aspx?rid=85888

"According to Bahn, another major update is the task force’s decision to not endorse specific therapies for Graves’ disease over others. "

"The new guidelines are patient-centric and emphasize that decisions regarding treatment of hyperthyroidism should be made jointly by the patient and the physician with consideration of both the specific clinical setting and the patient’s preference, Bahn said. She suggested providing a copy of the guidelines to interested patients in appropriate situations. "